Mutation of Mitochondrial DNA G13513A Presenting with Leigh Syndrome, Wolff-Parkinson-White Syndrome and Cardiomyopathy

Pediatrics and Neonatology

Volumn 49, Issue 4, 2008, Pages 145-149

  Wang, Shi Bing ^a   Weng, Wen Chin ^a   Lee, Ni Chung ^a   Hwu, Wuh Liang ^a   Fan, Pi Chuan ^a   Lee, Wang Tso ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

cardiomyopathy; electron transfer complex I; Leigh syndrome; Wolff Parkinson White syndrome

Indexed keywords

CAPTOPRIL; CARNITINE; CARVEDILOL; FUROSEMIDE; MITOCHONDRIAL DNA; PROPRANOLOL; THIAMINE; UBIDECARENONE;

ARTICLE; BASAL GANGLION; BRAIN STEM; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; DISEASE EXACERBATION; DIVERGENT STRABISMUS; ECHOCARDIOGRAPHY; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; GENE MUTATION; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LACTATE BLOOD LEVEL; LEIGH DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERIAQUEDUCTAL GRAY MATTER; POSITIVE END EXPIRATORY PRESSURE; PRESCHOOL CHILD; PSYCHOMOTOR RETARDATION; PTOSIS; REHABILITATION CARE; RESPIRATORY TRACT INFECTION; SPASTICITY; THALAMUS; WOLFF PARKINSON WHITE SYNDROME;

CARDIOMYOPATHY, HYPERTROPHIC; DNA, MITOCHONDRIAL; FEMALE; HUMANS; INFANT; LEIGH DISEASE; MUTATION; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 56849084177     PISSN: 18759572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1875-9572(08)60030-3     Document Type: Article

References (20)

1. Schmiedel J., Jackson S., Schafer J., and Reichmann H. Mitochondrial cytopathies. J Neurol 250 (2003) 267-277
2. Chol M., Lebon S., Benit P., et al. The mitochondrial DNA G13513A MELAS mutation in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiency. J Med Genet 40 (2003) 188-191
3. Santorelli F.M., Tanji K., Kulikova R., et al. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. Biochem Biophys Res Commun 238 (1997) 326-328
4. Bugiani M., Invernizzi F., Alberio S., et al. Clinical and molecular findings in children with complex I deficiency. Biochim Biophys Acta 1659 (2004) 136-147
5. Kirby D.M., Boneh A., Chow C.W., et al. Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease. Ann Neurol 54 (2003) 473-478
6. Ruiter E.M., Siers M.H., van den Elzen C., et al. The mitochondrial 13513G > A mutation is most frequent in Leigh syndrome combined with reduced complex I activity, optic atrophy and/or Wolff-Parkinson-White. Eur J Hum Genet 15 (2007) 155-161
7. Sudo A., Honzawa S., Nonaka I., and Goto Y. Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan. J Hum Genet 49 (2004) 92-96
8. Blok M.J., Spruijt L., de Coo I.F., Schoonderwoerd K., Hendrickx A., and Smeets H.J. Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease. J Med Genet 2007;44:e74. 9. Cardol P, Boutaffala L, Memmi S, Devreese B, Matagne RF, Remacle C. In Chlamydomonas, the loss of ND5 subunit prevents the assembly of whole mitochondrial complex I and leads to the formation of a low abundant 700 kDa subcomplex. Biochim Biophys Acta 1777 (2008) 388-396
9. Marin-Garcia J., and Goldenthal M.J. Understanding the impact of mitochondrial defects in cardiovascular disease: a review. J Card Fail 8 (2002) 347-361
10. Mashima Y., Kigasawa K., Hasegawa H., Tani M., and Oguchi Y. High incidence of pre-excitation syndrome in Japanese families with Leber's hereditary optic neuropathy. Clin Genet 50 (1996) 535-537
11. Nikoskelainen E.K., Savontaus M.L., Huoponen K., Antila K., and Hartiala J. Pre-excitation syndrome in Leber's hereditary optic neuropathy. Lancet 344 (1994) 857-858
12. Sproule D.M., Kaufmann P., Engelstad K., Starc T.J., Hordof A.J., and De Vivo D.C. Wolff-Parkinson-White syndrome in patients with MELAS. Arch Neurol 64 (2007) 1625-1627
13. Peters N.S., Rowland E., Bennett J.G., Green C.R., Anderson R.H., and Severs N.J. The Wolff-Parkinson-White syndrome: the cellular substrate for conduction in the accessory atrioventricular pathway. Eur Heart J 15 (1994) 981-987
14. Gollob M.H., Green M.S., Tang A.S., et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 344 (2001) 1823-1831
15. Hardie D.G., and Carling D. The AMP-activated protein kinasefuel gauge of the mammalian cell?. Eur J Biochem 246 (1997) 259-273
16. Yaplito-Lee J., Weintraub R., Jamsen K., Chow C.W., Thorburn D.R., and Boneh A. Cardiac manifestations in oxidative phosphorylation disorders of childhood. J Pediatr 150 (2007) 407-411
17. Silvestri G., Santorelli F.M., Shanske S., et al. A new mtDNA mutation in the tRNA(Leu(UUR)) gene associated with maternally inherited cardiomyopathy. Hum Mutat 3 (1994) 37-43
18. Scaglia F., Towbin J.A., Craigen W.J., et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 114 (2004) 925-931
19. Hayashi N., Geraghty M.T., and Green W.R. Ocular histopathologic study of a patient with the T 8993-G point mutation in Leigh's syndrome. Ophthalmology 107 (2000) 1397-1402
20. Carelli V., La Morgia C., Iommarini L., et al. Mitochondrial optic neuropathies: how two genomes may kill the same cell type?. Biosci Rep 27 (2007) 173-184